| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 05/04/2010 | US7709537 Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2010 | US7709514 benzimidazole-2-one-5-n-pentanoate; inhibiting Macrophage Migration Inhibitory Factor (MIF); rheumatoid arthritis |
| 05/04/2010 | US7709506 Kinase inhibitors to mediate disease and as antiinflammatory agents |
| 05/04/2010 | US7709500 Chemical compounds |
| 05/04/2010 | US7709486 antiviral compounds 1,4,8,11-tetraazacyclotetradecane derivatives for against HIV-infected cells, to inhibit the binding by the natural ligand to its chemokine receptor; viricides |
| 05/04/2010 | US7709480 2-(3,4-dichlorophenylamino)-4-thiocyanato-5-nitro-pyrimidine; 2-chloro-4-(2-acetylamino-ethylamino)-5-trifluoromethyl-pyrimidine; lung cancer |
| 05/04/2010 | US7709478 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 05/04/2010 | US7709461 Administering an aerosol of dry polysaccharide such as heparin of given particle size diameter |
| 05/04/2010 | US7709460 co-administration of a glutathione precursor (N-acetyl cysteine or alpha -lipoic acid) and hydroxocobalamin (a derivative of Vitamin B12) to patients with a functional Vitamin B12 deficiency and suffering from a neuropsychiatric abnormality |
| 05/04/2010 | US7709451 Method and composition for treating immune complex associated disorders |
| 05/04/2010 | US7709255 Nerve cells obtained by the method of the present invention have the flexibility to differentiate into a variety of types of neurons in vivo preferably without the need for application of growth factors; Embryonic Stem (ES) cells |
| 05/04/2010 | US7709220 Methods of monitoring treatment of BAFF-R related disease |
| 05/04/2010 | US7709020 Implantable device comprising phosphorus-containing macrolides |
| 05/04/2010 | US7709008 An recombinant serine-aspartate repeat (Sdr) protein from Staphylococcus epidermidis which is cell-wall associated, wherein the protein comprises the amino acid sequence 10-1742 of SEQ ID NO: 4.; multicomponent vaccines; coating polymericbiomaterials; catheters; prosthetics; nucleic acid probes |
| 05/04/2010 | US7708999 Inhibiting activity of fibroblast growth factor 8; preventing joint destruction, protecting cartilage, inhibiting growth of synovial membrane; diagnostic agent; antibody active ingredient |
| 05/04/2010 | CA2462456C Androstane 17-beta-carboxamides as androgen receptor modulators |
| 05/04/2010 | CA2440419C Azacycloalkyl substituted acetic acid derivatives for use as mmp inhibitors. |
| 05/04/2010 | CA2437767C Heterocyclic inhibitors of erk2 and uses thereof |
| 05/04/2010 | CA2427608C Condensed pyradizindione derivatives as pde inhibitors |
| 05/04/2010 | CA2427385C Nutritional composition for an immune condition |
| 05/04/2010 | CA2388243C Food materials useful in preventing and ameliorating metabolic bone diseases and preventives/remedies for metabolic bone diseases comprising these materials |
| 05/04/2010 | CA2385817C Substituted pyridines and pyridazines with angiogenesis inhibiting activity |
| 04/29/2010 | WO2010048592A1 Compositions comprising 4- (2- ( 5-br0m0-4- ( 1-cyclopropylnaphthalen-4-yl) -4h-1, 2, 4-triaz0l-3-ylthi0) acetamido -3-chlorobenzoic acid and pharmaceutically acceptable salts thereof |
| 04/29/2010 | WO2010048559A2 Phenylpyrazole inhibitors of store operated calcium release |
| 04/29/2010 | WO2010047361A1 Pharmaceutical composition improved in absorption through intestinal tract |
| 04/29/2010 | WO2010047127A1 PHENANTHROINDOLIZIDINE COMPOUND AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010047126A1 PHENANTHROINDOLIZIDINE DERIVATIVE AND NFκB INHIBITOR CONTAINING SAME AS ACTIVE INGREDIENT |
| 04/29/2010 | WO2010046791A1 Phosphodiestarase inhibitors |
| 04/29/2010 | WO2010045755A1 Glycosyl-derivatives of puerarin, pharmaceutical compositon, preparation method and use thereof |
| 04/29/2010 | WO2010006189A3 Small-molecule inhibitors of hif and angiogenesis |
| 04/29/2010 | WO2009152493A9 Use of apolipoproteins to decrease inflammation |
| 04/29/2010 | WO2009131553A3 Methods of altering bone growth by administration of sost or wise antagonist or agonist |
| 04/29/2010 | US20100105953 Human Adam-10 Inhibitors |
| 04/29/2010 | US20100105915 Chemokine receptor binding heterocyclic compounds |
| 04/29/2010 | US20100105896 Pharmaceutical compounds |
| 04/29/2010 | US20100105775 Amino acid salts of prostaglandins |
| 04/29/2010 | US20100105773 Use of resolvins and docosatrienes and analogues thereof for the treatment of angiogenesis and ocular neovascularization |
| 04/29/2010 | US20100105766 Composition for inhibition or prevention of bone density reduction |
| 04/29/2010 | US20100105762 Therapeutic agent for periodontal disease and alveolar bone loss due to surgery |
| 04/29/2010 | US20100105759 H19 silencing nucleic acid agents for treating rheumatoid arthritis |
| 04/29/2010 | US20100105681 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors |
| 04/29/2010 | US20100105632 Use of anabolic agents, anti-catabolic agents, antioxidant agents, and analgesics for protection, treatment and repair of connective tissues in humans and animals |
| 04/29/2010 | US20100105624 Calcitonin drug-oligomer conjugates, and uses thereof |
| 04/29/2010 | US20100104651 Pharmaceutical Compositions Containing Diacerein |
| 04/29/2010 | US20100104638 Extended release oral acetaminophen/tramadol dosage form |
| 04/29/2010 | US20100104582 CD200 and its receptor, CD200R, modulate bone mass via the differentiation of osteoclasts |
| 04/29/2010 | US20100104575 Polynucleotides and polypeptide sequences involved in the process of bone remodeling |
| 04/29/2010 | US20100104564 Altered Antibody Fc Regions and Uses Thereof |
| 04/29/2010 | US20100104563 Interleukin-18 specific immunoglobulins for treatment and prevention of autoimmune, respiratory, reproductive, heart, connective tissue, liver, bone and arthritic disorders |
| 04/29/2010 | DE102009004436A1 Verwendung einer Tirucallensäure, einer Lupansäure oder einer Robursäure als Arzneimittel Using a Tirucallensäure, a Lupansäure or Robur acid as a drug |
| 04/29/2010 | CA2740810A1 Phenanthroindolizidine compound and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2740807A1 Phenanthroindolizidine derivative and nf.kappa.b inhibitor containing same as active ingredient |
| 04/29/2010 | CA2739882A1 Pharmaceutical composition improving intestinal absorption |
| 04/29/2010 | CA2735956A1 Phosphodiestarase inhibitors |
| 04/28/2010 | EP2180053A2 Wisp polypeptides and therapeutical applications thereof |
| 04/28/2010 | EP2179738A2 Use of mesenchymal stem cells for treating osteoporosis |
| 04/28/2010 | EP2179030A1 Human disc tissue |
| 04/28/2010 | EP2178881A2 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmaceutical compositions and novel use as met inhibitors |
| 04/28/2010 | EP2178873A1 6-phenyl-1h-imidazo[4,5-c]pyridine-4-carbonitrile derivatives as cathepsin inhibitors |
| 04/28/2010 | EP2178840A1 Azabiphenylaminobenzoic acid derivatives as dhodh inhibitors |
| 04/28/2010 | EP2178526A1 Injectable pharmaceutical compositions containing panthenol |
| 04/28/2010 | EP1420785B1 Substituted indeno [1,2-c]isoquinoline derivatives and methods of use thereof |
| 04/28/2010 | EP1363640B1 Nucleic acid derivatives |
| 04/28/2010 | EP1347751B1 Methods of treating bone cancer and the pain associated therewith using endothelin antagonists |
| 04/28/2010 | CN1824009B Multipurpose medicinal composition capable of oral administration and external use |
| 04/28/2010 | CN1761686B Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 04/28/2010 | CN1698686B 'Duyiwei' soft capsule and its preparation |
| 04/28/2010 | CN1658877B Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom |
| 04/28/2010 | CN1620284B Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material, and process and tool for producing it |
| 04/28/2010 | CN1596266B Specific binding agents of human angiopoietin-2 |
| 04/28/2010 | CN1556808B Cosmetic comprising heterocyclic compound based on N6-substituted adenine, |
| 04/28/2010 | CN1496271B Method of treating diseases in association with decrease in expression of AOP-1 gene or AOP-1 and remedies for diseases |
| 04/28/2010 | CN101698684A Method for extracting polysaccharose from ginseng and application |
| 04/28/2010 | CN101698091A Formula for cervical spondylosis |
| 04/28/2010 | CN101698072A Traditional Chinese medicine composite for treating rheumatic arthritis and preparation method thereof |
| 04/28/2010 | CN101698069A Traditional Chinese medicine preparation for treating cervical vertigo |
| 04/28/2010 | CN101698058A Medicine for treating chronic arthralgia and preparation method thereof |
| 04/28/2010 | CN101698033A Big plaster for treating various rheumatic osteopathy and traumatic injuries |
| 04/28/2010 | CN101698020A Traditional Chinese medicine preparation for treating femoral head necrosis and preparation method thereof |
| 04/28/2010 | CN101698006A Bone-knitting medicine |
| 04/28/2010 | CN101014560B Wikstroemia indeca extract, their production and use in the production of anti-inflammatory pharmaceutical |
| 04/27/2010 | USRE41287 Cyclic agonists and antagonists of C5A receptors and G Protein-coupled receptors |
| 04/27/2010 | USRE41286 cartilage regeneration and repair product that induces cell ingrowth into a bioresorbable material and cell differentiation into cartilage tissue; comprises at least one TGF beta protein and at least one bone morphogenetic protein |
| 04/27/2010 | US7705050 Amides, useful in the inhibition of IL-8-induced chemotaxis of neutrophils |
| 04/27/2010 | US7705015 Substituted pyrroline kinase inhibitors |
| 04/27/2010 | US7704952 treating diabetes or obesity using isolated polypeptide is covalently modified with a water-soluble polymer |
| 04/27/2010 | US7704943 Angiogenesis inhibitors; using transglutaminase; antitumor agents; anticancer agents |
| 04/27/2010 | CA2435552C A drug for the treatment of osteonecrosis and for the management of patients at risk of developing osteonecrosis |
| 04/27/2010 | CA2431645C Methods of treating hormonal deficiencies in women undergoing estrogen replacement therapy |
| 04/27/2010 | CA2422378C Pyrazole compounds useful as protein kinase inhibitors |
| 04/27/2010 | CA2323776C Cytokine receptor common gamma chain like |
| 04/27/2010 | CA2321951C Dietary control of arachidonic acid metabolism |
| 04/22/2010 | WO2010045402A1 Trpv1 antagonists |
| 04/22/2010 | WO2010045401A1 Trpv1 antagonists |
| 04/22/2010 | WO2010045229A2 Protecting and repairing cartilage and musculoskeletal soft tissues |
| 04/22/2010 | WO2010045190A1 Fused heteroaryl diamide compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010045188A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors |
| 04/22/2010 | WO2010044681A1 A medicinal product and treatment |
| 04/22/2010 | WO2010044411A1 Phenylisonicotinic acid derivative and use thereof for medical purposes |
| 04/22/2010 | WO2010044410A1 Biaryl isonicotinic acid derivative and medical application of same |